Table 1

clinical data summary for breast cancer patients

Subtype

Receptor Status

Number

Age

Cancer Type

Grade

Metastasis

Tumor Size


1- <40

19 - INV

7 - G1

2 locally Recurrent

Min = 0.5

LuminalA

ER+ | PR+ & HER2-

24

20-[40,65]

4 - DCIS

10 - G2

3 Distant Metastasis

Max = 8

3->65

1 - u

5 - G3

18 No

Mean = 2.550526

2 - u

4- <40

9 - INV

2 - G1

1 locally Recurrent

Min = 0.2

LuminalB

ER+ | PR+ & HER2+

15

9-[40,65]

6 - DCIS

5 - G2

2 Distant Metastasis

max = 5.4

2->65

7 - G3

12 No

mean = 2.205556

1 - u

2- <40

8 - INV

0 - G1

0 locally Recurrent

min = 0.9

HER2Plus

ER- & PR- & HER2+

10

8-[40,65]

2 - DCIS

0 - G2

4 Distant Metastasis

max = 11

0->65

10 -G3

6 No

mean = 3.8

0- <40

15 - INV

1 - G1

3 locally Recurrent

min = 0.7

BasalLike

ER- & PR- & HER2-

19

18-[40,65]

4 - DCIS

3 - G2

3 Distant Metastasis

max = 6

1->65

14 -G3

13 No

mean = 2.5

1 - u

1- <40

2 - INV

1 - G1

0 locally Recurrent

Unknown

Missing

12

9-[40,65]

2 - DCIS

1 - G2

2 Distant Metastasis

2->65

8 - u

0 - G3

1 No

10 - u


INV: invasive; DCIS: Ductal Carcinoma in Situ; u: unknown

Zhang and Chen BMC Medical Genomics 2013 6(Suppl 1):S6   doi:10.1186/1755-8794-6-S1-S6

Open Data